G-quadruplex binding ligands: From naturally occurring to rationally designed molecules

Current Pharmaceutical Design

Volumn 18, Issue 14, 2012, Pages 1948-1972

  Le, Tuong Vy Thi ^a   Han, Sujin ^b   Chae, Junghyun ^b   Park, Hyun Ju ^a  

^a Sungkyunkwan University   (South Korea)

^b Sungshin Women's University   (South Korea)

Author keywords

DNA G quadruplex; Oncogene promoter G quadruplex; RNA G quadruplex; Telomere; Telomeric RNA

Indexed keywords

ACRIDINE; ANTHRAQUINONE; ASCIDIDEMIN; BERBERINE; COPPER; CORALYNE; CORONENE; CRYPTOLEPINE; DACTINOMYCIN; DAUNORUBICIN; DISTAMYCIN A; DOUBLE STRANDED DNA; DOXORUBICIN; GUANINE QUADRUPLEX; LIGAND; MANGANESE; NAPHTHALENE; NEOMYCIN; PALMATINE; PERYLENE; PORPHYRIN; QUARFLOXIN; QUERCETIN; RNA; RUTOSIDE; SABARUBICIN; SAMERIDINE; SANGUINARINE; TELOMESTATIN; UNINDEXED DRUG;

BINDING AFFINITY; COMPUTATIONAL FLUID DYNAMICS; CYTOTOXICITY; DNA BINDING; DNA BINDING MOTIF; DNA STRUCTURE; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; IC 50; LIGAND BINDING; MOLECULE; NONHUMAN; PH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; REVIEW; SCREENING; STOICHIOMETRY; STUDY DESIGN; SYNTHESIS; SYNTHETIC BIOLOGY;

ACRIDINES; ANTHRAQUINONES; BERBERINE; DNA; DRUG DESIGN; G-QUADRUPLEXES; HUMANS; INDOLE ALKALOIDS; LIGANDS; OXAZOLES; PORPHYRINS; QUINOLINES; RNA;

EID: 84860143903     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799958431     Document Type: Review

References (247)

1. Patel DJ, Phan AT, Kuryavyi V. Human telomere oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res 2007; 35: 7429-7455.
2. Neidle S, Parkinson GN. The structure of telomeric DNA. Curr Opin Struct Biol 2003; 13: 275-283.
3. Gellert M, Lipsett MN, Davies DR, Helix formation by guanylic acid. Proc Natl Acad Sci USA 1962; 48: 2013-2018.
4. Todd AK, Johnston M, Neidle S. Highly prevalent putative quadruplex sequence motifs in human DNA. Nucleic Acids Res 2005; 33: 2901-2907.
5. Huppert JL, Balainframanian S. Prevalence of quadruplexes in the human genome. Nucleic Acids Res 2005; 33: 2908-2916.
6. Zahler AM, Williamson JR, Cech TR, Prescott DM. Inhibition of telomerase by G-quartet DNA structures. Nature 1991; 350: 718-720.
7. Phan AT. Human telomeric G-quadruplex; structure of DNA and RNA sequences. FEBS J 2010; 277: 1107-1117.
8. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-673.
9. Stewart SA, Weinberg RA. Telomeres: cancer to human aging. Annu Rev Cell Dev Biol 2006; 22: 531-557.
10. Chai W, Shay JW, Wright WE. Human cells maintain their te-lomere overhangs at senescence. Mol Cell Biol 2005; 25: 2158-2168.
11. Sedivy JM. Telomeres limit cancer growth by inducing senescence: long-sought in vivo evidence obtained. Cancer Cell 2007; 11: 389-391.
12. Feldser DM, Greider CW. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 2007; 11: 461-469.
13. Cosme-Blanco W, Shen MF, Lazar AJF, et al. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep 2007; 8: 497-503.
14. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-791.
15. Hahn WC. Telomere and telomerase dynamics in human cells.Curr Mol Med 2005; 5: 227-231.
16. Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci USA 2002; 99: 11593-11598.
17. Simonsson T, Pecinka P, Kubista M. DNA tetraplex formation in the control region of c-myc. Nucleic Acids Res 1998; 26: 1167-1172.
18. Rankin S, Reszka AP, Huppert J, et al. Putative DNA quadruplex formation within the human c-kit oncogene. J Am Chem Soc 2005; 127: 10584-10589.
19. Dai J, Dexheimer TS, Chen D, et al. An intramolecular G-quadruplex structure with mixed parallel/antiparallel G-strands formed in the human BCL-2 promoter region in solution. J Am Chem Soc 2006; 128: 1096-1098.
20. Cogoi S, Xodo LE. G-Quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription. Nucleic Acids Res 2006; 34: 2536-2549.
21. De Armond R, Wood S, Sun D, Hurley LH, Ebbinghaus SW. Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter. Biochemistry 2005; 44: 16341-16350.
22. Xu Y, Sugiyama H. Formation of the G-quadruplex and i-motif structures in retinoblastoma susceptibility genes (Rb). Nucleic Acids Res 2006; 34: 949-954.
23. Guo K, Pourpak A, Beetz-Rogers K, Gokhale V, Sun D, Hurley LH. Formation of pseudosymmetrical G-quadruplex and i-Motif structures in the proximal promoter region of the RET oncogene. J Am Chem Soc 2007; 129: 10220-10228.
24. Sun D, Liu WJ, Guo K, et al. The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents. Mol Cancer Ther 2008; 7: 880-889.
25. Wieland M, Hartig JS. RNA quadruplex-based modulation of gene expression. Chem Biol 2007; 14: 757-763.
26. Horard B, Gilson E. Telomeric RNA enters the game. Nat Cell Biol 2008; 10: 113-115.
27. Englund EA, Xu Q, Witschi MA, Appella DH. PNA-DNA duplexes, triplexes, and quadruplexes are stabilized with trans-cyclopentane units. J Am Chem Soc 2006; 128: 16456-16457.
28. Nielsen JT, Arar K, Petersen M. NMR solution structures of LNA (locked nucleic acid) modified quadruplexes. Nucleic Acids Res 2006; 34: 2006-2014.
29. Hurley LH. DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer 2002; 2: 188-200.
30. Nelson SM, Ferguson LR, Denny WA. DNA and the chromosome: varied targets for chemotherapy. Cell Chromosome 2004; 3: 2-28.
31. Hurley LH. Secondary DNA structures as molecular targets for cancer therapeutics. Biochem Soc Trans 2001; 29: 692-696.
32. Sun D, Thompson B, Cathers BE, et al. Inhibition of human telom-erase by a G-quadruplex-interactive compound. J Med Chem 1997; 40: 2113-2116.
33. Shin-ya K, Wierzba K, Matsuo K, et al. Telomestatin, a novel telomerase inhibitor from streptomyces anulatus. J Am Chem Soc 2001; 123: 1262-1263.
34. Kim MY, Vankayalapati H, Shin-ya K, Wierzba K, Hurley LH. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J Am Chem Soc 2002; 124: 2098-2099.
35. Agrawal S, Ojha RP, Maiti S. Energetics of the human tel-22 quad-ruplex-telomestatin interaction: a molecular dynamics study. J Phys Chem B 2008; 112: 6828-6836.
36. Sumi M, Tauchi T, Sashida G, et al. A G-quadruplex interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia. Int J Oncol 2004; 24: 1481-1487.
37. Tauchi T, Shin-ya K, Sashida G, et al. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene 2006; 25: 5719-5725.
38. Tahara H, Shin-ya K, Seimiya H, Yamada H, Tsuruo T, Ide T. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells. Oncogene 2006; 25: 1955-1966.
39. Liu W, Sun D, Hurley LH. Binding of G-quadruplex interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells. Nucleosides, Nucleotides and Nucleic Acids 2005; 24: 1801-1815.
40. Binz N, Shalaby T, Rivera P, Shin-Ya K, Grotzer MA. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells. Euro J Cancer 2005; 41: 2873-2881.
41. Seenisamy J, Bashyam S, Gokhale V, et al. Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure. J Am Chem Soc 2005; 127: 2944-2959.
42. Dexheimer TS, Sun D, Hurley LH. Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter. J Am Chem Soc 2006; 128: 5404-5415.
43. Sun D, Guo K, Rusche JJ, Hurley LH. Facilitation of a structural transition in the polypurine /polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex interactive agents. Nucleic Acids Res 2005; 33: 6070-6080.
44. Doi T, Yoshida M, Shin-ya K. Takahashi T. Total synthesis of (R)-telomestatin. Organic Lett 2006; 8: 4165-4167.
45. Linder J, Garner TP, Williams HE, Searle MS, Moody CJ. Te-lomestatin: formal total synthesis and cation-mediated interaction of its seco-derivatives with G-quadruplexes. J Am Chem Soc 2011; 133: 1044-1051.
46. Minhas GS, Pilch DS, Kerrigan JE, LaVoie EJ, Rice JE. Synthesis and G-quadruplex stabilizing properties of a series of oxazole-containing macrocycles. Bioorg Med Chem Lett 2006; 16: 3891-3895.
47. Barbieri CM, Srinivasan AR, Rzuczek SG, Rice JE, LaVoie EJ, Pilch DS. Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA. Nucleic Acids Res 2007; 35: 3272-3286.
48. Tera M, Sohtome Y, Ishizuka H, et al. Design and synthesis of telomestatin derivatives and their inhibitory activity of telomerase. Heterocycles 2006; 69: 505-514.
49. Rzuczek SG, Pilch DS, LaVoie EJ, Rice JE. Lysinyl macrocyclic hexaoxazoles: synthesis and selective G-quadruplex stabilizing properties. Bioorg Med Chem Lett 2008; 18: 913-917.
50. Tera M, Ishizuka H, Takagi M, Suganuma M, Shin-ya K, Naga-sawa K. Macrocyclic hexaoxazoles as sequence and mode-selective G-quadruplex binders. Angew Chem Inter Ed 2008; 47: 5557-5560.
51. Satyanarayana M, Kim YA, Rzuczek SG, et al. Macrocyclic hexaoxazoles: influence of aminoalkyl infstituents on RNA and DNA G-quadruplex stabilization and cytotoxicity. Bioorg Med Chem Lett 2010; 20: 3150-3154.
52. Iida K, Tera M, Hirokawa T, Shin-ya K, Nagasawa K. G-quadruplex recognition by macrocyclic hexaoxazole (6OTD) di-mer: greater selectivity than monomer. Chem Commun 2009; 42: 6481-6483.
53. Iida K, Tera M, Hirokawa T, Shin-ya K, Nagasawa K. Synthesis of macrocyclic hexaoxazole (6OTD) dimers, containing guanidine and amine functionalized side chains, and an evaluation of their te-lomeric G4 stabilizing properties. J Nucleic Acids 2010; Article ID 217627, 9 pages.
54. Tera M, Iida K, Ishizuka H, et al. Synthesis of a potent G-quadruplex-binding macrocyclic heptaoxazole. ChemBioChem 2009; 10: 431-435.
55. Jantos K, Rodriguez R, Ladame S, Shirude PS, Balainframanian S. Oxazole-based peptide macrocycles: a new class of G-quadruplex binding ligands. J Am Chem Soc 2006; 128: 13662-13663.
56. Chakraborty TK, Arora A, Roy S, Kumar N, Maiti S. Furan based cyclic oligopeptides selectively target G-quadruplex. J Med Chem 2007; 50: 5539-5542.
57. Shirude PS, Gillies ER, Ladame S, et al. Macrocyclic and helical oligoamides as a new class of G-quadruplex ligands. J Am Chem Soc 2007; 129: 11890-11891.
58. Jena PV, Shirude PS, Okumus B, et al. G-quadruplex DNA bound by a synthetic ligand is highly dynamic. J Am Chem Soc 2009; 131: 12522-12523.
59. Agarwal T, Roy S, Chakraborty TK, Maiti S. Furan based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription. Bioorg Med Chem Lett 2010; 20: 4346-4349.
60. Naasani I, Seimiya H, Yamori T, Tsuruo T. FJ5002: a potent te-lomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res 1999; 59: 4004-4011.
61. Wu HL, Hsu CY, Liu WH, Yung BY. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int J Cancer 1999; 81: 923-929.
62. Ren J, Chaires JB. Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry 1999; 38: 16067-16075.
63. Franceschin M, Rossetti L, D'Ambrosio A, et al. Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorg Med Chem Lett 2006; 16: 1707-1711.
64. Zhang WJ, Ou TM, Lu YJ, et al. 9-Infstituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA. Bioorg Med Chem 2007; 15: 5493-5501.
65. Ma Y, Ou TM, Tan JH, et al. Synthesis and evaluation of 9-O-infstituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands. Bioorg Med Chem Lett 2009; 19: 3414-3417.
66. Ma Y, Ou TM, Tan JH, et al. Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from berberine: a new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene. Eur J Med Chem 2011; 46: 1906-1913.
67. Bhadra K, Kumar GS. Interaction of berberine, palmatine, cora-lyne, and sanguinarine to quadruplex DNA: a comparative spectro-scopic and calorimetric study. Biochim Biophys Acta 2011; 1810: 485-496.
68. Bai LP, Hagihara M, Jiang ZH, Nakatani K. Ligand binding to tandem G-quadruplexes from human telomeric DNA. ChemBio-Chem 2008; 9: 2583-2587.
69. Tackie AN, Bove G, Sharaf MHM, et al. Cryptospirolepine, a unique spiro-nonacyclic alkaloid isolated from cryptolepis sangui-nolenta. J Nat Prod 1993; 56: 653-670.
70. Caprio V, Guyen B, Opoku-Boahen Y, et al. A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline. Bioorg Med Chem Lett 2000; 10: 2063-2066.
71. Guyen B, Schultes CM, Hazel P, Mann J, Neidle S. Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. Org Biomol Chem 2004; 2: 981-988.
72. Zhou JM, Zhu X. F, Lu YJ, et al. Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quin-doline derivatives, in human cancer cell lines. Oncogene 2006; 25: 503-511.
73. Zhou JL, Lu YJ, Ou TM, et al. Synthesis and evaluation of quindo-line derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase. J Med Chem 2005; 48: 7315-7321.
74. Ou TM, Lu YJ, Zhang C, et al. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. J Med Chem 2007; 50: 1465-1474.
75. Lu YJ, Ou TM, Tan JH, et al. 5-N-methylated quindoline derivatives as telomeric G-quadruplex stabilizing ligands: effects of 5-N positive charge on quadruplex binding affinity and cell proliferation. J Med Chem 2008; 51: 6381-6392.
76. Asagi M, Toyama A, Takeuchi H. Binding affinity and mode of distamycin A with A/T stretches in double-stranded DNA: Importance of the terminal A/T residues. Biophys Chem 2010; 149 (1-2): 34-39.
77. Martino L, Virno A, Pagano B, et al. Structural and thermodynamic studies of the interaction of distamycin A with the parallel quadru-plex structure [d(TGGGGT)]4. J Am Chem Soc 2007; 129 (51): 16048-16056.
78. Cosconati S, Marinelli L, Trotta R, et al. Structural and conforma-tional requisites in DNA quadruplex groove binding: Another piece to the puzzle. J Am Chem Soc 2010; 132: 6425-6433.
79. Guittat L, De Cian A, Rosu F, et al. Ascididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro. Biochim Biophys Acta 2005; 1724: 375-384.
80. Sun H, Tang Y, Xiang J, et al. Spectroscopic studies of the interaction between quercetin and G-quadruplex DNA. Bioorg Med Chem Lett. 2006; 16: 3586-3589.
81. Sun HX; Xiang JF, Tang YL, Xu GZ. Regulation and recognization of the extended G-quadruplex by rutin. Biochem Biophys Res Commun 2007; 352: 942-946.
82. Wu X, Qin G, Cheung KK, Cheng KF. New alkaloids from Isatis indigotica. Tetrahedron 1997; 53: 13323-13328.
83. Tan JH, Ou TM, Hou JQ, et al. Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA. J Med Chem 2009; 52: 2825-2835.
84. Chen FM, Sha F, Chin KH, Chou SH. Binding of actinomycin D to single-stranded DNA of sequence motifs d(TGTCTnG) and d(TGTnGTCT). Biophys J 2003; 84: 432-439.
85. Bailey SA, Graves DE, Rill R. Binding of actinomycin D to the T(G)nT motif of double-stranded DNA: determination of the guanine requirement in nonclassical, non-GpC binding sites. Biochemistry 1994; 33: 11493-11500.
86. Paramasivan S, Bolton PH. Mix and measurefluorescence screening for selective quadruplex binders. Nucleic Acids Res 2008; 36: 102-106.
87. Hudson JS, Brooks SC, Graves DE. Interactions of actinomycin D with human telomeric G-quadruplex DNA. Biochemistry 2009; 48: 4440-4447.
88. Kang HJ, Park HJ. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder. Biochemistry 2009; 48: 7392-7398.
89. Zagotto G, Gatto B, Moro S, Sissi C, Palumbo M. Anthracyclines: recent developments in their separation and quantitation. J Chroma-togr B 2001; 764: 161-171.
90. Clark GR, Pytel PD, Squire CJ, Neidle S. Structure of the first parallel DNA quadruplex-drug complex. J Am Chem Soc 2003; 125: 4066-4067.
91. Manet I, Manoli F, Zambelli B, et al. Affinity of the anthracycline antitumor drugs Doxorubicin and Sabarubicin for human telomeric G-quadruplex structures. Phys Chem Chem Phys 2011; 13: 540-551.
92. Perry PJ, Reszka AP, Wood AA, et al. Human telomerase inhibition by regioisomeric diinfstituted amidoanthracene-9,10-diones. J Med Chem 1998; 41: 4873-4884.
93. Perry PJ, Gowan SM, Reszka AP, et al. 1,4- and 2,6-diinfstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. J Med Chem 1998; 41: 3253-3260.
94. Zagotto G, Sissi C, Moro S, et al. Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-infstituted anthracenedione derivatives. Bioorg Med Chem 2008; 16: 354-361.
95. Huang HS, Huang KF, Li CL, et al. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-infstituted amido-anthraquinone derivatives. Bioorg Med Chem 2008; 16: 6976-6986.
96. Neidle S, Read MA. G-quadruplexes as therapeutic targets. Bio-polymers 2000; 56: 195-208.
97. Perry PJ, Read MA, Davies RT, et al. 2,7-Diinfstituted amidofluo-renone derivatives as inhibitors of human telomerase. J Med Chem 1999; 42: 2679-2684.
98. Alcaro S, Artese A, Iley JN, et al. Rational design, synthesis, biophysical and antiproliferative evaluation of fluorenone derivatives with DNA G-quadruplex binding properties. ChemMedChem 2010; 5: 575-583.
99. Huang HS, Chen TC, Chen RH, et al. Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,11-dione homologues. Bioorg Med Chem 2009; 17: 7418-7428.
100. Perry PJ, Gowan SM, Read MA, Kelland LR, Neidle S. Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif. Anticancer Drug Des 1999; 14: 373-382.
101. Read MA, Wood AA, Harrison RJ, et al. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. J Med Chem 1999; 42: 4538-4546.
102. Harrison RJ, Gowan SM, Kelland LR, Neidle S. Human telomerase inhibition by infstituted acridine derivatives. Bioorg Med Chem Lett 1999; 9: 2463-2468.
103. Laronze-Cochard M, Kim YM, Brassart B, Riou JF, Laronze JY, Sapi J. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-infstituted acridines as potent telomeric G-quadruplex ligands. Eur J Med Chem 2009; 44: 3880-3888.
104. Harrison RJ, Reszka AP, Haider SM, et al. Evaluation of by diinfstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. Bioorg Med Chem Lett 2004; 14: 5845-5849.
105. Bazzicalupi C, Chioccioli M, Sissi C, et al. Modeling and biological investigations of an unusual behavior of novel synthesized acridine-based polyamine ligands in the binding of double helix and G-quadruplex DNA. ChemMedChem 2010; 5: 1995-2005.
106. Campbell NH, Smith DL, Reszka AP, Neidle S, O'Hagan D. Fluorine in medicinal chemistry: /?-fluorination of peripheral pyrrolidines attached to acridine ligands affects their interactions with G-quadruplex DNA. Org Biomol Chem 2011; 9: 1328-1331.
107. Haider SM, Parkinson GN, Neidle S. Structure of a G-quadruplex-ligand complex. J Mol Biol 2003; 326: 117-125.
108. Read M, Harrison RJ, Romagnoli B, et al. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proc Natl Acad Sci USA 2001; 98: 4844-4849.
109. Harrison RJ, Cuesta J, Chessari G, et al. Triinfstituted acridine derivatives as potent and selective telomerase inhibitors. J Med Chem 2003; 46: 4463-4476.
110. Schultes CM, Guyen B, Cuesta J, Neidle S. Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino infstituents as potent G-quadruplex binding telomerase inhibitors. Bioorg Med Chem Lett 2004; 14: 4347-4351.
111. Moore MJB, Schultes CM, Cuesta J, et al. Triinfstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. J Med Chem 2006; 49: 582-599.
112. Burger AM, Dai F, Schultes CM, et al. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res 2005; 65: 1489-1496.
113. Fu YT, Keppler BR, Soares J, Jarstfer MB. BRACO19 analog dimers with improved inhibition of telomerase and hPot 1. Bioorg Med Chem 2009; 17: 2030-2037.
114. Debray J, Zeghida W, Jourdan M, et al. Synthesis and evaluation of fused bispyrimidinoacridines as novel pentacyclic analogues of quadruplex-binder BRACO-19. Org Biomol Chem 2009; 7: 5219-5228.
115. Stanslas J, Hagan DJ, Ellis MJ, et al. Antitumor polycyclic acridi-nes. Part 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridines. J Med Chem 2000; 43: 1563-1572.
116. Heald RA, Modi C, Cookson JC, et al. Antitumor polycyclic acridines. 8. Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. J Med Chem 2002; 45: 590-597.
117. Cookson JC, Dai F, Smith V, et al. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents. Mol Pharmacol 2005; 68: 1551-1558.
118. Cookson JC, Heald RA, Stevens MF. Antitumor polycyclic acridi-nes synthesis and pharmaceutical profiles of pentacyclic acridinium salts designed to destabilize telomeric integrity. J Med Chem 2005; 48: 7198-7207.
119. Lauhon CT, Szostak J W. RNA aptamers that bind flavin and nicotinamide redox cofactors. J Am Chem Soc 1995; 117: 1246-1257.
120. Bejugam M, Sewitz S, Shirude PS, Rodriguez R, Shahid R, Ba-lainframanian S. Tri-infstituted isoalloxazines as a new class of G-quadruplex binding ligands: small molecule regulation of c-kit oncogene expression. J Am Chem Soc 2007; 129: 12926-12927.
121. Folini M, Pivetta C, Zagotto G, et al. Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioi-somer. Biochem Pharmacol 2010; 79: 1781-1790.
122. Le Gresley A, Abdullah A, Chawla D, et al. Diacrylamides as selective G-quadruplex ligands in in vitro and in vivo assays. Med Chem Commun 2011; 2: 466-70.
123. Mergny JL, Lacroix L, Teulade-Fichou MP, et al. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc Natl Acad Sci USA 2001; 98: 3062-3067.
124. Hounsou C, Guittat L, Monchaud D, et al. G-quadruplex recognition by quinacridines: a SAR, NMR, and biological study. ChemMedChem 2007; 2: 655-666.
125. Teulade-Fichou MP, Carrasco C, Guittat L, et al. Selective recognition of G-quadruplex telomeric DNA by a bis(quinacridine) macro-cycle. J Am Chem Soc 2003; 125: 4732-4740.
126. Allain C, Monchaud D, Teulade-Fichou MP. FRET templated by G-quadruplex DNA: a specific ternary interaction using an original pair of donor/acceptor partners. J Am Chem Soc 2006; 128: 11890-11893.
127. Gabelica V, Baker ES, Teulade-Fichou MP, De Pauw E, Bowers MT. Stabilization and structure of telomeric and c-myc region intramolecular G-quadruplexes: the role of central cations and small planar ligands. J Am Chem Soc 2007; 129: 895-904.
128. Granzhan A, Monchaud D, Saettel N, Guedin A, Mergny JL, Teu-lade-Fichou MP. One ring to bind them all-Part II: identification of promising G-quadruplex ligands by screening of cyclophane-type macrocycles. J Nucleic Acids 2010; Article ID 460561, 11 pages.
129. Wang JC. DNA topoisomerases. Annu Rev Biochem 1996; 65: 635-692.
130. Permana PA, Snapka RM, Shen LL, Chu DTW, Clement JJ, Plattner JJ. Quinobenzoxazines: a class of novel antitumor qui-nolones and potent mammalian DNA topoisomerase II catalytic inhibitors. Biochemistry 1994; 33: 11333-11339.
131. Duan W, Vankayalapati H, Rangan A, et al. Design and synthesis of fluoroquinophenoxazines that interact with G-quadruplexes and their biological effects. Mol Cancer Ther 2001; 1: 103-120.
132. Kim M, Duan W, Guzman MG, Hurley LH. Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes. J Med Chem 2003; 46: 571-583.
133. Wilson WD, Sugiyama H. First international meeting on quadru-plex DNA. ACS Chem Biol 2007; 2: 589-594.
134. Drygin D, Siddiqui-Jain A, O'Brien S, et al. Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res 2009; 69: 7653-7661.
135. Fedoroff OY, Salazar M, Han H, Chemeris VV, Kerwin SM, Hurley LH. NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 1998; 37: 12367-12374.
136. Han H, Cliff CL, Hurley LH. Accelerated assembly of G-quadruplex structures by a small molecule. Biochemistry 1999; 38: 6981-6986.
137. Rossetti L, Franceschin M, Bianco A, Ortaggi G, Savino M. Perylene diimides with different side chains are selective in inducing different G-quadruplex DNA structures and in inhibiting telom-erase. Bioorg Med Chem Lett 2002; 12: 2527-2533.
138. Rossetti L, Franceschin M, Schirripa S, Bianco A, Ortaggi G, Sav-ino M. Selective interactions of perylene derivatives having different side chains with inter- and intramolecular G-quadruplex DNA structures. A correlation with telomerase inhibition. Bioorg Med Chem Lett 2005; 15: 413-420.
139. Samudrala R, Zhang X, Wadkins RM, Mattern DL. Synthesis of a non-cationic, water-soluble perylenetetracarboxylic diimide and its interactions with G-quadruplex-forming DNA. Bioorg Med Chem 2007; 15: 186-193.
140. Sissi C, Lucatello L, Paul Krapcho A, et al. Tri-, tetra- and hepta-cyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition. Bioorg Med Chem 2007; 15: 555-562.
141. Franceschin M, Lombardo CM, Pascucci E, et al. The number and distances of positive charges of polyamine side chains in a series of perylene diimides significantly influence their ability to induce G-quadruplex structures and inhibit human telomerase. Bioorg Med Chem 2008; 16: 2292-2304.
142. Micheli E, Lombardo CM, D'Ambrosio D, Franceschin M, Neidle S, Savino M. Selective G-quadruplex ligands: the significant role of side chain charge density in a series of perylene derivatives. Bioorg Med Chem Lett 2009; 19: 3903-3908.
143. Micheli E, D'Ambrosio D, Franceschin M, Savino M. Water soluble cationic perylene derivatives as possible telomerase inhibitors: the search for selective G-quadruplex targeting. Mini Rev Med Chem 2009; 9: 1622-1632.
144. Franceschin M, Pascucci E, Alvino A, et al. New highly hydro-soluble and not self-aggregated perylene derivatives with three and four polar side-chains as G-quadruplex telomere targeting agents and telomerase inhibitors. Bioorg Med Chem Lett 2007; 17: 2515-2522.
145. Franceschin M, Alvino A, Casagrande V, et al. Specific interactions with intra- and intermolecular G-quadruplex DNA structures by hydrosoluble coronene derivatives: a new class of telomerase inhibitors. Bioorg Med Chem 2007; 15: 1848-1858.
146. Hampel SM, Sidibe A, Gunaratnam M, Riou JF, Neidle S. Tetra-infstituted naphthalene diimide ligands with selectivity for te-lomeric G-quadruplexes and cancer cells. Bioorg Med Chem Lett 2010; 20: 6459-6463.
147. Di Antonio M, Doria F, Richter SN, et al. Quinone methides tethered to naphthalene diimides as selective G-quadruplex alkylating agents. J Am Chem Soc 2009; 131: 13132-13141.
148. Wheelhouse RT, Sun D, Han H, Han FX, Hurley LH. Cationic porphyrins as telomerase inhibitors: the interaction of tetra-(N-methyl-4-pyridyl)porphine with quadruplex DNA. J Am Chem Soc 1998; 120: 3261-3262.
149. Han FX, Wheelhouse RT, Hurley LH. Interactions of TMPyP4 and TMPyP2 with quadruplex DNA. Structural basis for the differential effects on telomerase inhibition. J Am Chem Soc 1999; 121: 3561-3570.
150. Izbicka E, Wheelhouse RT, Raymond E, et al. Effects of cationic porphyrins as G-quadruplex-interactive agents in human tumor cells. Cancer Res 1999; 59: 639-644.
151. Rha SY, Izbicka E, Lawrence R, et al. Effect of telomere and te-lomerase interactive agents on human tumor and normal cell lines. Clin Cancer Res 2000; 6: 987-993.
152. Shi DF, Wheelhouse RT, Sun D, Hurley LH. Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J Med Chem 2001; 44: 4509-4523.
153. Kim MY, Gleason-Guzman M, Izbicka E, Nishioka D, Hurley LH. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. Cancer Res 2003; 63: 3247-3256.
154. Grand CL, Powell TJ, Nagle RB, et al. Mutations in the G-quadruplex silencer element and their relationship to c-MYC over-expression, NM23 repression, and therapeutic rescue. Proc Natl Acad Sci USA 2004; 101: 6140-6145.
155. Freyer MW, Buscaglia R, Kaplan K, Cashman D, Hurley LH, Lewis EA. Biophysical studies of the c-MYC NHE III1 promoter: model quadruplex interactions with a cationic porphyrin. Biophys J 2007; 92: 2007-2015.
156. Lubitz I, Borovok N, Kotlyar A. Interaction of monomolecular G4-DNA nanowires with TMPyP: evidence for intercalation. Biochemistry 2007; 46: 12925-12929.
157. Haq I, Trent JO, Chowdhry BZ, Jenkins TC. Intercalative G-tetraplex stabilization of telomeric DNA by a cationic porphyrin. J Am Chem Soc 1999; 121: 1768-1779
158. Phan AT, Kuryavyi V, Gaw HY, Patel DJ. Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter. Nat Chem Biol 2005; 1: 167-173.
159. Parkinson GN, Ghosh R, Neidle S. Structural basis for binding of porphyrin to human telomeres. Biochemistry 2007; 46: 2390-2397.
160. Wang P, Ren L, He H, Liang F, Zhou X, Tan Z. A phenol quaternary ammonium porphyrin as a potent telomerase inhibitor by selective interaction with quadruplex DNA. ChemBioChem 2006; 7: 1155-1159.
161. Ma H, Zhang M, Zhang D, et al. Pyridyl-infstituted corrole iso-mers: synthesis and their regulation to G-quadruplex structures. Chem Asin J 2010; 5: 114-122.
162. Du Y, Zhang D, Chen W, Zhang M, Zhou Y, Zhou X. Cationic N-confused porphyrin derivative as a better molecule scaffold for G-quadruplex recognition. Bioorg Med Chem 2010; 18: 1111-1116.
163. Goncalves DPN, Rodriguez R, Balainframanian S, Sanders JKM. Tetramethylpyridiniumporphyrazines - a new class of G-quadruplex inducing and stabilising ligands. Chem Commun 2006; 45: 4685-4687.
164. Ren L, Zhang A, Huang J, et al. Quaternary ammonium zinc phthalocyanine: inhibiting telomerase by stabilizing G quadru-plexes and inducing G-quadruplex structure transition and formation. ChemBioChem 2007; 8: 775-780.
165. Alzeer J, Vummidi BR, Roth PJC, Luedtke NW. Guanidinium-modified phthalocyanines as high-affinity G-quadruplex fluorescent probes and transcriptional regulators. Angew Chem Int Ed 2009; 48: 9362-5.
166. Yaku H, Murashima T, Miyoshi D, Sugimoto N. Anionic phthalo-cyanines targeting G-quadruplexes and inhibiting telomerase activity in the presence of excessive DNA duplexes. Chem Commun 2010; 46: 5740-5742.
167. Riou JF, Guittat L, Mailliet P, et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc Natl Acad Sci USA 2002; 99: 2672-2677.
168. Gomez D, Aouali N, Londono-Vallejo A, et al. Resistance to the short-term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration. J Biol Chem 2003; 278: 50554-50562.
169. Gomez D, Lemarteleur T, Lacroix L, Mailliet P, Mergny JL, Riou JF. Telomerase down regulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res 2004; 32: 371-379.
170. Douarre C, Gomez D, Morjani H, et al. Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence. Nucleic Acids Res 2005; 33: 2192-2203.
171. Lemarteleur T, Gomez D, Paterski R, Mandine E, Mailliet P, Riou JF. Stabilization of the c-myc gene promoter quadruplex by specific ligands inhibitors of telomerase. Biochem Biophys Res Com-mun 2004; 323: 802-808.
172. Pennarun G, Granotier C, Gauthier LR, et al. Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands. Oncogene 2005; 24: 2917-2928.
173. De Cian A, DeLemos E, Mergny JL, Teulade-Fichou MP, Mon-chaud D. Highly efficient G-quadruplex recognition by bisquino-linium compounds. J Am Chem Soc 2007; 129: 1856-1857.
174. Rodriguez R, Müller S, Yeoman JA, Trentesaux C, Riou JF, Ba-lainframanian S. A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. J Am Chem Soc 2008; 130: 15758-15759.
175. Bugaut A, Rodriguez R, Kumari S, Hsua STD, Balainframanian S. Small molecule-mediated inhibition of translation by targeting a native RNA G-quadruplex. Org Biomol Chem 2010; 8: 2771-2776.
176. Peng D, Tan JH, Chen SB, Ou TM, Gu LQ, Huang ZS. Bis-aryldiketene derivatives: a new class of selective ligands for c-myc G-quadruplex DNA. Bioorg Med Chem 2010; 18: 8235-8242.
177. Moorhouse AD, Santos AM, Gunaratnam M, Moore M, Neidle S, Moses JE. Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. J Am Chem Soc 2006; 128: 15972-15973.
178. Sparapani S, Haider SM, Doria F, Gunaratnam M, Neidle S. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes. J Am Chem Soc 2010; 132: 12263-12272.
179. Drewe WC, Neidle S. Click chemistry assembly of G-quadruplex ligands incorporating a diarylurea scaffold and triazole linkers. Chem Commun 2008; 42: 5295-5297.
180. Moses JE, Ritson DJ, Zhang F, et al. A click chemistry approach to C3 symmetric, G-quadruplex stabilizing ligands. Org Biomol Chem 2010; 8: 2926-2930.
181. Lombardo CM, Martinez IS, Haider S, et al. Structure-based design of selective high-affinity telomeric quadruplex-binding ligands. Chem Commun 2010; 46: 9116-9118.
182. Dash J, Shirude PS, Hsu ST, Balainframanian S. Diarylethynyl amides that recognize the parallel conformation of genomic promoter DNA G-quadruplexes. J Am Chem Soc 2008; 130: 15950-15956.
183. Dash J, Waller ZA, Pantos GD, Balainframanian S. Synthesis and binding studies of novel diethynyl-pyridine amides with genomic promoter DNA G-quadruplexes. Chem Eur J 2011; 17: 4571-4581.
184. Li G, Huang J, Zhang M, et al. Bis(benzimidazole)pyridine derivative as a new class of G-quadruplex inducing and stabilizing ligand. Chem Commun 2008; 38: 4564-4566.
185. Jain AK, Reddy VV, Paul A, Muniyappa K, Bhattacharya S. Synthesis and evaluation of a novel class of G-quadruplex-stabilizing small molecules based on the 1,3-phenylene-bis(piperazinyl ben-zimidazole) system. Biochemistry 2009; 48: 10693-10704.
186. Bhattacharya S, Chaudhuri P, Jain AK, Paul A. Symmetrical bis-benzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition. Bioconjug Chem 2010; 21: 1148-1159.
187. Dash J, Shirude PS, Balainframanian S. G-quadruplex recognition by bis-indole carboxamides. Chem Commun 2008; 26: 3055-3057.
188. Wheelhouse RT, Jennings SA, Phillips VA, et al. Design, synthesis, and evaluation of novel biarylpyrimidines: a new class of ligand for unusual nucleic acid structures. J Med Chem 2006; 49: 5187-5198.
189. Drewe WC, Nanjunda R, Gunaratnam M, et al. Rational design of infstituted diarylureas: a scaffold for binding to G-quadruplex motifs. J Med Chem 2008; 51: 7751-7767.
190. Huang J, Li G, Wu Z, et al. Bisbenzimidazole to benzobisimida-zole: from binding B-form duplex DNA to recognizing different modes of telomere G-quadruplex. Chem Commun 2009; 8: 902-904.
191. Bianco S, Musetti C, Waldeck A, et al. Bis-phenanthroline derivatives as suitable scaffolds for effective G-quadruplex recognition. Dalton Trans 2010; 39: 5833-5841.
192. Georgiades SN, Abd Karim NH, Suntharalingam K, Vilar R. Interaction of metal complexes with G-quadruplex DNA. Angew Chem Int Ed 2010; 49: 4020-4034.
193. Keating LR, Szalai VA. Parallel stranded guanine quadruplex interactions with a cationic copper porphyrin. Biochemistry 2004; 43: 15891-15900.
194. Evans SE, Mendez MA, Turner KB, et al. End-stacking of copper cationic porphyrins on parallel-stranded guanine quadruplexes. J Biol Inorg Chem 2007; 12: 1235-1249.
195. Vialas C, Pratviel G, Meunier B. Oxidative damage generated by an oxo-metalloporphyrin onto the human telomeric sequence. Biochemistry 2000; 39: 9514-9522.
196. Maraval A, Franco S, Vialas C, Pratviel G, Blasco MA, Meunier B. Porphyrin-aminoquinoline conjugates as telomerase inhibitors. Org Biomol Chem 2003; 1: 921-927.
197. Dixon IM, Lopez F, Tejera AM, et al. A G-quadruplex ligand with 1000-fold selectivity over duplex DNA. J Am Chem Soc 2007; 129: 1502-1503.
198. Reed JE, Arnal AA, Neidle S, Vilar R. Stabilization of G-quadruplex DNA and inhibition of telomerase activity by square-planar nickel(II) complexes. J Am Chem Soc 2006; 128: 5992-5993.
199. Bertrand H, Monchaud D, De Cian A, Guillot R, Mergny JL, Teu-lade-Fichou MP. The importance of metal geometry in the recognition of G-quadruplex-DNA by metal-terpyridine complexes. Org Biomol Chem 2007; 5: 2555-2559.
200. Reed JE, Neidle S, Vilar R. Stabilisation of human telomeric quad-ruplex DNA and inhibition of telomerase by a platinum-phenanthroline complex. Chem Commun 2007; 42: 4366-4368.
201. Reed JE, White AJP, Neidle S, Vilar R. Effect of metal coordination on the interaction of infstituted phenanthroline and pyridine ligands with quadruplex DNA. Dalton Trans 2009; 14: 2558-2568.
202. Kieltyka R, Englebienne P, Fakhoury J, Autexier C, Moitessier N, Sleiman H. A platinum supramolecular square as an effective G-quadruplex binder and telomerase inhibitor. J Am Chem Soc 2008; 130: 10040-10041.
203. Yu H, Wang X, Fu M, Ren J, Qu X. Chiral metallo-supramolecular complexes selectively recognize human telomeric G-quadruplex DNA. Nucleic Acids Res 2008; 36: 5695-5703.
204. II complexes that display high affinity binding to duplex and quadruplex DNA. Chem Eur J 2006; 12: 4611-4619.
205. Shi S, Liu J, Yao T, et al. Promoting the formation and stabilization of G-quadruplex by dinuclear RuII Complex Ru2(obip)L4. Inorg Chem 2008; 47: 2910-2912.
206. Ma DL, Che CM, Yan SC. Platinum(II) complexes with dipyrido-phenazine ligands as human telomerase inhibitors and luminescent probes for G-quadruplex DNA. J Am Chem Soc 2009; 131: 1835-1846.
207. Bertrand H, Bombard S, Monchaud D, Teulade-Fichou MP. A platinum-quinacridine hybrid as a G-quadruplex ligand. J Biol Inorg Chem 2007; 12: 1003-1014.
208. Tuntiwechapikul W, Salazar M. Cleavage of telomeric G-quadruplex DNA with perylene-EDTA*Fe(II). Biochemistry 2001; 40: 13652-13658.
209. Tuntiwechapikul W, Lee JT, Salazar M. Design and synthesis of the G-quadruplex-specific cleaving reagent perylene-EDTA.iron(II). J Am Chem Soc 2001; 123: 5606-5607.
210. Isalan M, Patel SD, Balainframanian S, Choo Y. Selection of zinc fingers that bind single-stranded telomeric DNA in the G-quadruplex conformation. Biochemistry 2001; 40: 830-836.
211. Schouten JA, Ladame S, Mason SJ, Cooper MA, Balainframanian S. G-quadruplex-specific peptide-hemicyanine ligands by partial combinatorial selection. J Am Chem Soc 2003; 125: 5594-5595.
212. Ladame S, Schouten JA, Stuart J, Roldan J, Neidle S, Balainfra-manian S. Tetrapeptides induce selective recognition for G-quadruplexes when conjugated to a DNA-binding platform. Org Biomol Chem 2004; 2: 2925-2931.
213. Redman JE, Granadino-Roldan JM, Schouten JA, et al. Recognition and discrimination of DNA quadruplexes by acridine-peptide conjugates. Org Biomol Chem 2009; 7: 76-84.
214. Kaiser M, De Cian A, Sainlos M, Renner C, Mergny JL, Teulade-Fichou MP. Neomycin-capped aromatic platforms: quadruplex DNA recognition and telomerase inhibition. Org Biomol Chem 2006; 4: 1049-1057.
215. Xue L, Ranjan N, Arya DP. Synthesis and spectroscopic studies of the aminoglycoside (neomycin)-perylene conjugate binding to human telomeric DNA. Biochemistry 2011; 50: 2838-2849.
216. Casals J, Debethune L, Alvarez K, et al. Directing quadruplex-stabilizing drugs to the telomere: synthesis and properties of acridine-oligonucleotide conjugates. Bioconjug Chem 2006; 17: 1351-1359.
217. Paul A, Sengupta P, Krishnan Y, Ladame S. Combining G-quadruplex targeting motifs on a single peptide nucleic acid scaffold: a hybrid (3+1) PNA-DNA bimolecular quadruplex. Chem Eur J 2008; 14: 8682-8689.
218. Walters WP, Stahl MT, Murcko MA. Virtual screening - an overview. Drug Discov Today 1998; 3: 160-178.
219. Rester U. From virtuality to reality - Virtual screening in lead discovery and lead optimization: A medicinal chemistry perspective. Curr Opin Drug Discov Devel 2008; 11: 559-568.
220. Campbell NH, Parkinson GN, Reszka AP, Neidle S. Structural basis of DNA quadruplex recognition by an acridine drug. J Am Chem Soc 2008; 130: 6722-6724.
221. Read M, Harrison RJ, Romagnoli B, et al. Structure-based design of selective and poten G-quadruplex-mediated telomerse inhibitors. Proc Natl Acad Sci USA 2001; 98 (9): 4844-4849.
222. Chen SB, Tan JH, Ou TM, et al. Pharmacophore-based discovery of triaryl-infstituted imidazole as new telomeric G-quadruplex ligand. Bioorg Med Chem Lett 2011; 21: 1004-1009.
223. Lee HM, Chan DSH, Yang F, et al. Identification of natural product Fonsecin B as a stabilizing ligand of c-myc G-quadruplex DNA by high-throughput virtual screening. Chem Commun 2010; 46: 4680-4682.
224. Chan DAH, Yang H, Kwan MHT, et al. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer. Biochimie 2011; 93: 1055-1064.
225. Ma DL, Lai TS, Chan FY, et al. Discovery of a drug-like G-quadruplex binding ligand by high-throughput docking. ChemMedChem 2008; 3: 881-884.
226. Wu P, Ma DL, Leung CH, et al. Stabilization of G-Quadruplex DNA with platinum(II) schiff base complexes: Luminescent probe and down-regulation of c-myc oncogene expression. Chem Eur J 2009; 15: 13008-13021.
227. Wang P, Leung CH, Ma DL, Yan SC, Che CM. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-Quadruplex DNA. Chem Eur J 2010; 16: 6900-6911.
228. Cosconati S, Marinelli L, Trotta R, et al. Tandem application of virtual screening and NMR experiments in the discovery of brand new DNA quadruplex groove binders. J Am Chem Soc 2009; 131: 16336-16337.
229. Chen X Q, Kuntz ID, Shafer RH. Spectroscopic recognition of guanine dimeric hairpin quadruplexes by a carbocyanine dye. Proc Natl Acad Sci USA 1996; 93: 2635-2639.
230. White EW, Tanious F, Ismail MA, et al. Structure-specific recognition of quadruplex DNA by organic cations: influence of shape, infstituents and charge. Biophys Chem 2007; 126: 140-153
231. Trotta R, De Tito S, Lauri I, et al. A more detailed picture of the interaction between virtual screening-derived hits and the DNA G-quadruplex: NMR, molecular modeling and ITC studies. Biochimie 2011; 93: 1280-1287.
232. Brassart B, Gomex D, De Cian A, et al. A new steroid derivative stabilizes G-quadruplexes and induces telomere uncapping in human tumor cells. Mol Pharmacol 2007; 72: 631-640.
233. Li Q, Xiang J, Li X, et al. Stabilizing parallel G-quadruplex DNA by a new class of ligands: Two non-planar alkaloids through interaction in lateral grooves. Biochimie 2009; 91: 811-819
234. Kumari S, Bugaut A, Huppert JL, Balainframanian S. An RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene modulates translation. Nat Chem Biol 2007; 3: 218-221.
235. Redon S, Reichenbach P, Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res 2010; 38: 5797-5806.
236. Gros J, Guédin A, Mergny JL, Lacroix L. G-Quadruplex formation interferes with P1 helix formation in the RNA component of telom-erase hTERC. ChemBioChem 2008; 9: 2075-2079.
237. De Cian A, Gros J, Guédin A, et al. DNA and RNA Quadruplex ligands. Nucleic Acids Symp Ser 2008; 52: 7-8.
238. Rzuczek SG, Pilch DS, Liu AA, Liu LF, LaVoie EJ, Rice JE. Mac-rocyclic pyridyl polyoxazoles: Selective RNA and DNA G-Quadruplex ligands as antitumor agents. J Med Chem 2010; 53(9): 3632-3644.
239. Collie GW, Sparapani S, Parkinson GN, Neidle S. Structural basis of telomeric RNA quadruplex-acridine ligand recognition. J Am Chem Soc 2011; 133: 2721-2728.
240. McLuckie KIE, Waller ZAE, Sanders DA, et al. G-quadruplex-binding benzo[a]phenoxazines down-regulate c-KIT expression in human gastric carcinoma cells. J Am Chem Soc 2011; 133: 2658-2663.
241. Bejugam M, Gunaratnam M, Muller S, et al. Targeting the c-kit promoter G-quadruplexes with 6-infstituted Indenoisoquinolines. ACS Med Chem Lett 2010; 1: 306-310.
242. Laronze-Cochard M, Cochard F, Daras E, et al. Synthesis and biological evaluation of new penta- and heptacyclic indolo- and quinolinocarbazole ring systems obtained via Pd(0) catalysed reductive N-heteroannulation. Org Biomol Chem 2010; 8: 4625-4636.
243. Ginnari-Satriani L, Casagrande V, Bianco A, Ortaggi G, Franceschin M. A hydrophilic three side-chained triazatruxene as a new strong and selective G-quadruplex ligand. Org Biomol Chem 2009; 7: 2513-2516.
244. Zhang H, Xiang JF, Hu HY, et al. Stabilizing G-quadruplex DNA by a scissors-shaped binaphthyl derivative through the entangling mode: cooperation of binaphthylene and the ethoxy chain. Biochemistry 2010; 49: 10351-10353.
245. Çetinkol Persil Ö, Engelhart AE, Nanjunda RK, Wilson WD, Hud NV. Infmicromolar, selective G-quadruplex ligands from one pot: thermodynamics and structural studies of human telomeric DNA binding by azacyanines. ChemBioChem 2008; 9: 1889-1892.
246. Rahman KM, Reszka AP, Gunaratnam M, et al. Biaryl polyamides as a new class of DNA quadruplex-binding ligands. Chem Com-mun 2009; 27: 4097-4099.
247. Stefan L, Guedin A, Amrane S, et al. DOTASQ as a prototype of nature-inspired G-quadruplex ligand. Chem Commun 2011; 47: 4992-4994.